Table 2

Clinicopathological parameters meta-analysis results

AnalysisNo. of
studies
No. of
patients
HR
(95% CI)
P valueModelHeterogeneity
(I2 %/P)
Harbord
test (P)
Age (≤55Y vs. >55Y)53430.73(0.40 to 1.33)0.31F0.0/0.970.39
Tumor size
(≤4cm vs. >4cm)
42901.76(0.90 to 3.41)0.10F0.0/0.940.45
FIGO stage
(I+II vs. III+IV)
32401.96(0.85 to 4.53)0.11F0.0/0.620.32
Histological grade
(G1+G2 vs. G3)
32081.95(0.82 to 4.64)0.13F0.0/0.650.79
Lymph node metastases
(N0 vs. N1+N2)
42912.57(1.28 to 5.16)0.00F0.0/0.840.39
Hemoglobin
(≤11.5g/dL vs. >11.5g/dL)
32260.90(0.43 to 1.91)0.79F0.0/0.500.96
Parametrial invasion
(yes vs. no)
32261.46(0.69 to 3.10)0.33F0.56/0.100.52
  • F:fixed-effect model; FIGO:International Federation of Gynaecology and Obstetrics; No:number.